[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520761":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":24,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Fifth Affiliated Hospital, Sun Yat-Sen University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"HCC group",null,"Patients who develop HCC during follow-up",{"label":13,"type":10,"description":14,"interventionNames":10},"non-HCC group","Patients who did not develop HCC during follow-up",[16],{"name":17,"affiliation":5,"role":18},"Yaqin Zhang, MD, Ph.D","STUDY_CHAIR",[20],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","13719282895","zhyaqin@mail.sysu.edu.cn",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Yaqin, Zhang","RECRUITING","Zhuhai","Guangdong","China","CN",{"type":33,"coordinates":34},"Point",[35,36],113.56778,22.27694,{"lat":36,"lon":35},[39],{"name":40,"role":21,"phone":22,"phoneExt":10,"email":23},"Yaqin Zhang",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100520761","study-on-the-quantitative-assessment-of-the-risk-of-hepatocellular-carcinoma-in-patients-with-chronic-liver-disease-using-multi-parameter-magnetic-resonance-imaging-100520761",false,"NCT06060769","Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging","Inclusion Criteria:\n\n* 1\\. Aged over 18 years old; 2. Liver function Child-Pugh classification A or B; 3. Patients with chronic liver disease who meet the diagnostic criteria for high-risk groups of liver cancer in the \"Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)\"; 4. Equipped with Gd-EOB-DTPA enhanced MRI scan images, including T1 mapping, T2 mapping, T2\\* mapping, T1ρ and other sequences; 5. With 5-year follow-up data.\n\nExclusion Criteria:\n\n* 1\\. Patients who are unable to undergo MRI scanning due to claustrophobia, abnormal renal function, etc.; 2. Patients who have undergone liver surgery in the past; 3. Patients with major diseases such as heart failure and tumors.",true,"ALL","18 Years",{"count":53,"type":54},1200,"ESTIMATED","OBSERVATIONAL","Quantitative MRI scanning parameters such as T1 mapping, T2 mapping, T1ρ, and elastography are used, combined with clinical and laboratory indicators, to predict the risk of liver cancer in patients with cirrhosis.",[58],"Cirrhosis； Tumor","2023-09-25",{"date":61,"type":62},"2023-09-29","ACTUAL",{"date":64,"type":62},"2023-09-01",{"date":66,"type":54},"2029-01-31",{"name":5,"class":6},1]